Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases

It is estimated that about 5–10% of ovarian and 2–5% of all breast cancer patients are carriers of a germline BRCA1 or BRCA2 gene mutation. Most families with detected BRCA1 or BRCA2 gene mutation are qualified for molecular testing on the basis of family history of breast or ovarian cancers. The pu...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Brozek, Izabela, Ratajska, Magdalena, Piatkowska, Magdalena, Kluska, Anna, Balabas, Aneta, Dabrowska, Michalina, Nowakowska, Dorota, Niwinska, Anna, Rachtan, Jadwiga, Steffen, Jan, Limon, Janusz
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Netherlands 2012
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3496543/
https://ncbi.nlm.nih.gov/pubmed/22395474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10689-012-9519-5
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller